Old Web
English
Sign In
Acemap
>
authorDetail
>
Mike Bybel
Mike Bybel
Sanofi Pasteur
Virology
Meningococcal disease
Immunology
Immunogenicity
Medicine
3
Papers
148
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children
2005
Pediatric Infectious Disease Journal
Michael E. Pichichero
Janet R. Casey
Mark M. Blatter
Edward P. Rothstein
Robert Ryall
Mike Bybel
Gregory Gilmet
Thomas Papa
Show All
Source
Cite
Save
Citations (104)
Immunogenicity and Immunological Priming of the Serogroup A Portion of a Bivalent Meningococcal A/C Conjugate Vaccine in 2-Year-Old Children
2003
The Journal of Infectious Diseases
Helen Joseph
Robert Ryall
Mike Bybel
Thomas Papa
Jenny MacLennan
Jim Buttery
Ray Borrow
Show All
Source
Cite
Save
Citations (20)
Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus Subcutaneous
2001
Clinical Infectious Diseases
Frederick L. Ruben
James E. Froeschle
Carlton K. Meschievitz
Kevin Chen
James N. George
Mary Kathryn Reeves-Hoché
Patricia Pietrobon
Mike Bybel
William C. Livingood
Lynn D. Woodhouse
Show All
Source
Cite
Save
Citations (24)
1